The prevalence of Alzheimer neuropathologic lesions is similar in blacks and whites

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 12, 2006, Pages 1143-1148

  Riudavets, Miguel A ^a,d   Rubio, Ana ^b   Cox, Christopher ^c   Rudow, Gay ^d   Fowler, David ^b   Troncoso, Juan C ^d  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b OFFICE OF THE CHIEF MEDICAL EXAMINER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; ApoE4; Autopsy; Gender; Prevalence; Race

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; PREVALENCE; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; BRAIN; ENTORHINAL CORTEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLES; PREVALENCE; SENILE PLAQUES; SEX DISTRIBUTION; TAU PROTEINS;

EID: 33845363674     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000248548.20799.a3     Document Type: Article

References (40)

1. Desai MM, Zhang P, Hennessy CH. Surveillance for morbidity and mortality among older adults - United States, 1995-1996. MMWR CDC Surveill Summ 1999;48:7-25
2. Gurland BJ, Wilder DE, Lantigua R, et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry 1999;14:481-93
3. Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001;56:49-56
4. Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998;279:751-55
5. Fillenbaum GG, Heyman A, Huber MS, et al. The prevalence and 3-year incidence of dementia in older black and white community residents. J Clin Epidemiol 1998;51:587-95
6. de la Monte SM, Hutchins GM, Moore GW. Racial differences in the etiology of dementia and frequency of Alzheimer lesions in the brain. J Natl Med Assoc 1989;81:644-52
7. Sandberg G, Stewart W, Smialek J, et al. The prevalence of the neuropathological lesions of Alzheimer's disease is independent of race and gender. Neurobiol Aging 2001;22:169-75
8. Pablos-Mendez A, Mayeux R, Ngai C, et al. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 1997;17:3534-41
9. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-23
10. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 1996;47:387-400
11. Hyman BT, Gomez-Isla T, Rebeck GW, et al. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Ann N Y Acad Sci 1996;802:1-5
12. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-20
13. Graff-Radford NR, Green RC, Go RC, et al. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch Neurol 2002;59:594-600
14. Sahota A, Yang M, Gao S, et al. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent. Ann Neurol 1997;42:659-61
15. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status. Arch Neurol 2003;60:185-89
16. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
17. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
18. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-48
19. McCullagh P, Nelder JA. Generalized Linear Models, 2nd ed. New York: Chapman and Hall, 1989
20. Hendrie HC. Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatry 1998;6:S3-18
21. Gao S, Hendrie HC, Hall KS, et al. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: A meta-analysis. Arch Gen Psychiatry 1998;55:809-15
22. Demirovic J, Prineas R, Loewenstein D, et al. Prevalence of dementia in three ethnic groups: The South Florida program on aging and health. Ann Epidemiol 2003;13:472-78
23. Small G. Meeting the challenges of vascular dementia. Introduction. Int J Clin Pract Suppl 2001;May:1-4
24. Froehlich TE, Bogardus ST Jr, Inouye SK. Dementia and race: Are there differences between African Americans and Caucasians? J Am Geriatr Soc 2001;49:477-84
25. Skoog I. Vascular aspects in Alzheimer's disease. J Neural Transm Suppl 2000;59:37-43
26. Mast BT, Fitzgerald J, Steinberg J, et al. Effective screening for Alzheimer's disease among older African Americans. Clin Neuropsychol 2001;15:196-202
27. Welsh KA, Fillenbaum G, Wilkinson W, et al. Neuropsychological test performance in African-American and white patients with Alzheimer's disease. Neurology 1995;45:2207-11
28. Fillenbaum GG, Huber M, Taussig IM. Performance of elderly white and African American community residents on the abbreviated CERAD Boston Naming Test. J Clin Exp Neuropsychol 1997;19:204-10
29. Eikelenboom P, Rozemuller JM, vanMuiswinkel FL. Inflammation and Alzheimer's disease: Relationships between pathogenic mechanisms and clinical expression. Exp Neurol 1998;154:89-98
30. McGeer EG, McGeer PL. Innate immunity in Alzheimer's disease: A model for local inflammatory reactions. Mol Interv 2001;1:22-29
31. Evans RM, Emsley CL, Gao S, et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans. Neurology 2000;54:240-42
32. Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003;60:940-46
33. Wolozin B, Kellman W, Ruosseau P, et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000;57:1439-43
34. Kawas C, Robert K. Epidemiology of dementia and Alzheimer disease. In: Terry RD, Bick KL, Sisodia SS, eds. Alzheimer Disease, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1999:95-116
35. Ohm TG, Kirca M, Bohl J, et al. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 1995;66:583-87
36. Breitner JC, Wyse BW, Anthony JC, et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: The Cache County Study. Neurology 1999;53:321-31
37. Meyer MR, Tschanz JT, Norton MC, et al. APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease. Nat Genet 1998;19:321-22
38. Kamboh MI, Evans RW, Aston CE. Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women. Atherosclerosis 1995;117:73-81
39. Greenberg SM, Rebeck GW, Vonsattel JP, et al. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995;38:254-59
40. Strozyk D, White LR, Petrovitch H, et al. Sex hormones and neuropathology in elderly men: the HAAS. Neurobiol Aging 2006 Feb 23 [Epub ahead of print]